Edward F. Srour
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation 84
- Genetics top 0.5%
- Mesenchymal stem cell research 42
- Virus-based gene therapy research 17
- Immunology top 1%
- Immune Cell Function and Interaction 27
- Immunotherapy and Immune Responses 24
- T-cell and B-cell Immunology 21
- Oncology top 1%
- Cancer Cells and Metastasis 12
- Cancer Research top 2%
-
- Pluripotent Stem Cells Research 12
- Co-authors
- Hal E. BroxmeyerMervin C. YöderAndré GothotGiao HangocD. Wade ClappBrahmananda R. ChittetiJ BrandtScott Cooper
- Cited by
- HematologyGeneticsImmunology
- Journals
- New England Journal of Medicine (1 paper)Cell (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Edward F. Srour
163 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Hematology 3.0k
- Genetics 1.5k
- Immunology 2.0k
- Oncology 1.8k
- Cancer Research 654
Countries citing papers authored by Edward F. Srour
This map shows the geographic impact of Edward F. Srour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward F. Srour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward F. Srour more than expected).
Fields of papers citing papers by Edward F. Srour
This network shows the impact of papers produced by Edward F. Srour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward F. Srour. The network helps show where Edward F. Srour may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward F. Srour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 19 | |
| 2 | Osteoclast-mediated bone loss observed in a COVID-19 mouse model | 2022 | 2 |
| 3 | 2021 | 12 | |
| 4 | 2018 | 19 | |
| 5 | 2017 | 16 | |
| 6 | 2017 | 35 | |
| 7 | 2016 | 22 | |
| 8 | Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock | 2015 | 0 |
| 9 | 2015 | 238 | |
| 10 | 2014 | 14 | |
| 11 | 2011 | 12 | |
| 12 | 2010 | 55 | |
| 13 | 2006 | 16 | |
| 14 | Calpain inhibition down-regulates Akt and induces death of non-cycling breast cancer cells | 2004 | 1 |
| 15 | 1999 | 2 | |
| 16 | 1995 | 2 | |
| 17 | 1993 | 18 | |
| 18 | 1992 | 6 | |
| 19 | The AIS CELLector: a new technology for stem cell purification. | 1992 | 6 |
| 20 | 1988 | 29 |
About Edward F. Srour
Edward F. Srour is a scholar working on Hematology, Genetics and Immunology, having authored 165 papers that have together received 7.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (84 papers), Mesenchymal stem cell research (42 papers), Immune Cell Function and Interaction (27 papers), Immunotherapy and Immune Responses (24 papers), T-cell and B-cell Immunology (21 papers), Virus-based gene therapy research (17 papers), Cancer Cells and Metastasis (12 papers) and Pluripotent Stem Cells Research (12 papers). The work is most often cited by research in Hematology (3.0k citations), Genetics (1.5k citations) and Immunology (2.0k citations). Edward F. Srour has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Hal E. Broxmeyer, Mervin C. Yöder, André Gothot, Giao Hangoc, D. Wade Clapp, Brahmananda R. Chitteti, J Brandt, Scott Cooper, Robert S. Hoffman and Susan Rice. Their work appears in journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.